ER stress: A novel therapeutic target in pancreatic cancer.

被引：0
|
作者：
Nawrocki, ST [1 ]
Carew, JS [1 ]
Pino, MS [1 ]
Highshaw, RA [1 ]
Andtbacka, RH [1 ]
Dunner, K [1 ]
Bornmann, W [1 ]
Huang, P [1 ]
Boise, LH [1 ]
Abbruzzese, JL [1 ]
McConkey, DJ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9038S / 9038S
页数：1
相关论文
共 50 条
  • [31] Short-form Ron kinase as a novel therapeutic target in ovarian cancer.
    Bieniasz, Magdalena
    Welm, Alana L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [32] Autophagy as a therapeutic target in pancreatic cancer
    Max Piffoux
    Erwan Eriau
    Philippe A. Cassier
    British Journal of Cancer, 2021, 124 : 333 - 344
  • [33] Autophagy as a therapeutic target in pancreatic cancer
    Piffoux, Max
    Eriau, Erwan
    Cassier, Philippe A.
    BRITISH JOURNAL OF CANCER, 2021, 124 (02) : 333 - 344
  • [34] eNOS as a therapeutic target in pancreatic cancer
    Barrientos, Katharine S.
    Lampson, Benjamin L.
    Kendall, Stephan D.
    Counters, Christopher M.
    CANCER RESEARCH, 2011, 71
  • [35] Molecular characterization of pancreatic cancer. Therapeutic implications
    Westphalen, C. Benedikt
    Heinrich, Kathrin
    Boeck, Stefan
    Heinemann, Volker
    ONKOLOGE, 2019, 25 (08): : 704 - 709
  • [36] bFGF as a therapeutic target for chemosensitization in colorectal cancer.
    Yu, Bei
    Wei, Yong
    Song, Saeheum
    Wientjes, M. Guillaume
    Au, Jessie Ls
    CANCER RESEARCH, 2006, 66 (08)
  • [37] BRAF is an important therapeutic target in human cancer.
    Marais, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6268S - 6268S
  • [38] DNA methylation as a therapeutic target in ovarian cancer.
    Strathdee, G
    Appleton, K
    Plumb, J
    Brown, R
    CLINICAL CANCER RESEARCH, 2000, 6 : 4505S - 4505S
  • [39] Novel targeting methods for pancreatic cancer.
    Knowlton, Andrea
    Restuccia, Antonietta
    Delitto, Daniel
    Trevino, Jose
    Hudalla, Greg
    Wallet, Shannon
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [40] HSP90 as a Therapeutic Target for Gemcitabine and 5-Fluorouracil refractory Pancreatic cancer.
    Rabofski, J.
    Vashist, Y.
    Kalinina, T.
    Guengor, C.
    Izbicki, J.
    Yekebas, E.
    ONKOLOGIE, 2010, 33 : 151 - 152
12345